TY - JOUR

T1 - Vector-borne diseases

AU - More, Simon J.

AU - Bicout, Dominique

AU - Bøtner, Anette

AU - Butterworth, Andrew

AU - Calistri, Paolo

AU - Koeijer, Aline De

AU - Depner, Klaus

AU - Edwards, Sandra

AU - Garin-Bastuji, Bruno

AU - Good, Margaret

AU - Gortazar Schmidt, Christian

AU - Michel, Virginie

AU - Miranda, Miguel Angel

AU - Nielsen, Søren Saxmose

AU - Raj, Mohan

AU - Sihvonen, Liisa

AU - Spoolder, Hans

AU - Thulke, Hans-Hermann

AU - Velarde, Antonio

AU - Willeberg, Preben

AU - Winckler, Christoph

AU - Bau, Andrea

AU - Beltran-Beck, Beatriz

AU - Carnesecchi, Edoardo

AU - Casier, Pascal

AU - Czwienczek, Ewelina

AU - Dhollander, Sofie

AU - Georgiadis, Marios

AU - Gogin, Andrey

AU - Pasinato, Luca

AU - Richardson, Jane

AU - Riolo, Francesca

AU - Rossi, Gianluca

AU - Watts, Matthew

AU - Lima, Eliana

AU - Stegeman, Jan Arend

PY - 2017

Y1 - 2017

N2 - After a request from the Europea n Commission, EFSA’s Panel on Animal Health and Welfaresummarised the main characteristics of 36 vector-borne disease s (VBDs) in 36 web-based storymaps.The risk of introduction in the EU through movement of livestock or pets was assessed for eac h of the36 VBDs individually, using a semiquantitative Metho d to INTegrate all relevant RISK aspects(MINTRI SK model), which was further modified to a European scale into the EFSA-VBD-RISK-m odel .Only eight of the 36 VBD-agents had an overall rate of introduction in the EU (being the combinationof the rate of entry, vector transmission and establishment) which was estimated to be above 0.001introductions per year. These were Crimean-Congo haemorrhagic fever virus, bluetongue virus, WestNile virus, Schmallenberg virus, Hepatozoon canis, Leishmania infantum, Bunyamwera virus andHighlands J. virus. For these eight dise ases, the annual extent of spread was assessed, assuming theimplementation of available, authorised prevention and control measures in the EU. Further, theprobability of overwintering was assessed, as well as the possible impact of the VBDs on public health,animal health and farm production. For the other 28 VBD-agents for which the rate of introduction wasestimated to be very low, no further asse ssments were made. Due to the uncertainty related to someparameters used for the risk assessment or the instable or unpredictability disease situation in some ofthe source regions, it is recommended to update the assessment when new information becomesavailable. Since this risk assessment was carried out for large regions in the EU for many VBD-agents,it should be considered as a first screening. If a more detailed risk assessment for a specificVBDiswished for on a national or subnational level, the EFSA-VBD-RISK-model is freely available for thispurpose.

AB - After a request from the Europea n Commission, EFSA’s Panel on Animal Health and Welfaresummarised the main characteristics of 36 vector-borne disease s (VBDs) in 36 web-based storymaps.The risk of introduction in the EU through movement of livestock or pets was assessed for eac h of the36 VBDs individually, using a semiquantitative Metho d to INTegrate all relevant RISK aspects(MINTRI SK model), which was further modified to a European scale into the EFSA-VBD-RISK-m odel .Only eight of the 36 VBD-agents had an overall rate of introduction in the EU (being the combinationof the rate of entry, vector transmission and establishment) which was estimated to be above 0.001introductions per year. These were Crimean-Congo haemorrhagic fever virus, bluetongue virus, WestNile virus, Schmallenberg virus, Hepatozoon canis, Leishmania infantum, Bunyamwera virus andHighlands J. virus. For these eight dise ases, the annual extent of spread was assessed, assuming theimplementation of available, authorised prevention and control measures in the EU. Further, theprobability of overwintering was assessed, as well as the possible impact of the VBDs on public health,animal health and farm production. For the other 28 VBD-agents for which the rate of introduction wasestimated to be very low, no further asse ssments were made. Due to the uncertainty related to someparameters used for the risk assessment or the instable or unpredictability disease situation in some ofthe source regions, it is recommended to update the assessment when new information becomesavailable. Since this risk assessment was carried out for large regions in the EU for many VBD-agents,it should be considered as a first screening. If a more detailed risk assessment for a specificVBDiswished for on a national or subnational level, the EFSA-VBD-RISK-model is freely available for thispurpose.

U2 - 10.2903/j.efsa.2017.4793

DO - 10.2903/j.efsa.2017.4793

M3 - Journal article

VL - 15

JO - E F S A Journal

JF - E F S A Journal

SN - 1831-4732

IS - 5

M1 - 4793

ER -